BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37517447)

  • 1. Effectiveness and safety of misoprostol-only for first-trimester medication abortion: An updated systematic review and meta-analysis.
    Raymond EG; Weaver MA; Shochet T
    Contraception; 2023 Nov; 127():110132. PubMed ID: 37517447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Misoprostol Alone for First-Trimester Medical Abortion: A Systematic Review.
    Raymond EG; Harrison MS; Weaver MA
    Obstet Gynecol; 2019 Jan; 133(1):137-147. PubMed ID: 30531568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-trimester medical abortion with mifepristone 200 mg and misoprostol: a systematic review.
    Raymond EG; Shannon C; Weaver MA; Winikoff B
    Contraception; 2013 Jan; 87(1):26-37. PubMed ID: 22898359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical methods for first trimester abortion.
    Kulier R; Gülmezoglu AM; Hofmeyr GJ; Cheng LN; Campana A
    Cochrane Database Syst Rev; 2004; (2):CD002855. PubMed ID: 15106180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical methods for first trimester abortion.
    Kulier R; Gülmezoglu AM; Hofmeyr GJ; Cheng LN; Campana A
    Cochrane Database Syst Rev; 2004; (1):CD002855. PubMed ID: 14973995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical methods for first trimester abortion.
    Kulier R; Kapp N; Gülmezoglu AM; Hofmeyr GJ; Cheng L; Campana A
    Cochrane Database Syst Rev; 2011 Nov; 2011(11):CD002855. PubMed ID: 22071804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical termination for pregnancy in early first trimester (≤ 63 days) using combination of mifepristone and misoprostol or misoprostol alone: a systematic review.
    Abubeker FA; Lavelanet A; Rodriguez MI; Kim C
    BMC Womens Health; 2020 Jul; 20(1):142. PubMed ID: 32635921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of a hospital outpatient day procedure for medication abortion at 13-18 weeks gestation: Findings from Nepal
    Blum J; Karki C; Tamang A; Shochet T; Shrestha A; Tuladhar H; Karki A; Sharma J; Abbas DF; Dragoman M; Winikoff B
    Contraception; 2019 Dec; 100(6):451-456. PubMed ID: 31491379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical methods for mid-trimester termination of pregnancy.
    Wildschut H; Both MI; Medema S; Thomee E; Wildhagen MF; Kapp N
    Cochrane Database Syst Rev; 2011 Jan; 2011(1):CD005216. PubMed ID: 21249669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic Review of the Effectiveness, Safety, and Acceptability of Mifepristone and Misoprostol for Medical Abortion in Low- and Middle-Income Countries.
    Ferguson I; Scott H
    J Obstet Gynaecol Can; 2020 Dec; 42(12):1532-1542.e2. PubMed ID: 32912726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-administered versus provider-administered medical abortion.
    Gambir K; Kim C; Necastro KA; Ganatra B; Ngo TD
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD013181. PubMed ID: 32150279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two medical abortion regimens for late first-trimester termination of pregnancy: a prospective randomized trial.
    Dalenda C; Ines N; Fathia B; Malika A; Bechir Z; Ezzeddine S; Hela C; Badis CM
    Contraception; 2010 Apr; 81(4):323-7. PubMed ID: 20227549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical preparation for first trimester surgical abortion.
    Kapp N; Lohr PA; Ngo TD; Hayes JL
    Cochrane Database Syst Rev; 2010 Feb; (2):CD007207. PubMed ID: 20166091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes of medication abortion using misoprostol-only: A retrospective chart review at an abortion provider organization in the United States.
    Raymond EG; Weaver MA; Shochet T; Grant M; Boyd K; Koenig LR; Upadhyay U
    Contraception; 2023 Oct; 126():110109. PubMed ID: 37390948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First trimester abortion with mifepristone and vaginal misoprostol.
    Knudsen UB
    Contraception; 2001 May; 63(5):247-50. PubMed ID: 11448463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation.
    Hamoda H; Ashok PW; Flett GM; Templeton A
    BJOG; 2005 Aug; 112(8):1102-8. PubMed ID: 16045525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Termination of pregnancy at 9-13 weeks' amenorrhoea with mifepristone and misoprostol.
    Ashok PW; Flett GM; Templeton A
    Lancet; 1998 Aug; 352(9127):542-3. PubMed ID: 9716062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Medical induced abortion].
    Bettahar K; Pinton A; Boisramé T; Cavillon V; Wylomanski S; Nisand I; Hassoun D
    J Gynecol Obstet Biol Reprod (Paris); 2016 Dec; 45(10):1490-1514. PubMed ID: 27818118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mifepristone With Buccal Misoprostol for Medical Abortion: A Systematic Review.
    Chen MJ; Creinin MD
    Obstet Gynecol; 2015 Jul; 126(1):12-21. PubMed ID: 26241251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical abortion in the late first trimester: a systematic review.
    Kapp N; Eckersberger E; Lavelanet A; Rodriguez MI
    Contraception; 2019 Feb; 99(2):77-86. PubMed ID: 30444970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.